Analytical Data
-
Gene name
MSC
- Application
-
Alternative Names
ABF-1; ABF1; Activated B cell factor 1; Activated B-cell factor 1; bHLHa22; Class A basic helix-loop-helix protein 22; Msc; MUSC_HUMAN; Musculin; MYOR
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60682
-
Expression Region
1-206 aa
-
AA Sequence
MSTGSVSDPE EMELRGLQRE YPVPASKRPP LRGVERSYAS PSDNSSAEEE DPDGEEERCA LGTAGSAEGC KRKRPRVAGG GGAGGSAGGG GKKPLPAKGS AAECKQSQRN AANARERARM RVLSKAFSRL KTSLPWVPPD TKLSKLDTLR LASSYIAHLR QLLQEDRYEN GYVHPVNLTW PFVVSGRPDS DTKEVSAANR LCGTTA
-
Molecular Weight
22.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of MSC (Mesenchymal Stem Cell) recombinant proteins has gained significant attention in recent years due to their potential in regenerative medicine and tissue engineering. MSCs are multipotent stem cells that can differentiate into various cell types, including bone, cartilage, and fat cells, and possess immunomodulatory properties that make them ideal candidates for therapeutic applications. The ability to generate recombinant proteins from MSCs allows researchers to harness their unique growth factors and signaling molecules, which can promote tissue repair and modulate immune responses. This research is crucial for developing novel treatments for degenerative diseases, trauma, and autoimmune disorders. By utilizing genetic engineering techniques, scientists are able to enhance the expression of specific proteins that can either be secreted by MSCs or presented on their surface, thereby improving their efficacy in clinical applications. Furthermore, understanding the molecular pathways involved in MSC function through the study of recombinant proteins can lead to breakthroughs in personalized medicine and the development of targeted therapies. With ongoing advancements in biotechnology, the exploration of MSC recombinant proteins holds promise for innovative strategies in combating various health challenges and improving patient outcomes in regenerative therapies.
